21 results
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
27 Jul 23
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
4:11pm
package he had while serving as President of Maravai’s Biologics Safety Testing segment. Mr. Martin ceased serving as President of Maravai’s Biologics
8-K
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
19 Oct 22
Departure of Directors or Certain Officers
4:05pm
compensation package, as previously disclosed in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission
10-Q
mh3g jyrucvsvir
12 May 21
Quarterly report
4:26pm
424B4
iy0cd jflp
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
tug2n
25 Mar 21
Draft registration statement
12:00am
10-K
wz75b47wa
22 Mar 21
Annual report
4:22pm
424B4
ah1xiog3n8fso976sj
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
EX-10.17
cvkagrpd6yj
29 Oct 20
IPO registration
5:04pm
S-1
EX-10.15
f75yy2qnsbzvg
29 Oct 20
IPO registration
5:04pm
S-1
3bgu0q8m k0d
29 Oct 20
IPO registration
5:04pm
DRS/A
upe frfz8nj6mfpeya
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.17
ugus 2r9heheeuvig7
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
0xol sw7pwb
14 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.15
sb6ri877l8 6gfi5
14 Oct 20
Draft registration statement (amended)
12:00am